NO922941L - Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener - Google Patents

Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener

Info

Publication number
NO922941L
NO922941L NO92922941A NO922941A NO922941L NO 922941 L NO922941 L NO 922941L NO 92922941 A NO92922941 A NO 92922941A NO 922941 A NO922941 A NO 922941A NO 922941 L NO922941 L NO 922941L
Authority
NO
Norway
Prior art keywords
aids
carbohydrate
arc
medicinals
procedures
Prior art date
Application number
NO92922941A
Other languages
English (en)
Other versions
NO922941D0 (no
Inventor
John-Erik Stig Hansen
Henrik Clausen
Original Assignee
Hafnia Bay Dev Corp Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafnia Bay Dev Corp Sa filed Critical Hafnia Bay Dev Corp Sa
Publication of NO922941D0 publication Critical patent/NO922941D0/no
Publication of NO922941L publication Critical patent/NO922941L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Et monoklonalt eller annet antistoff mot karbohydrat-antigen Tn kan benyttes for å hemme eller forsinke progresjo-nen av AIDS eller ARC. Antigenet kan benyttes i en vaksine for immunisering.
NO92922941A 1990-01-26 1992-07-24 Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener NO922941L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47066690A 1990-01-26 1990-01-26
PCT/EP1990/002161 WO1991011528A1 (en) 1990-01-26 1990-12-13 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens

Publications (2)

Publication Number Publication Date
NO922941D0 NO922941D0 (no) 1992-07-24
NO922941L true NO922941L (no) 1992-09-17

Family

ID=23868522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922941A NO922941L (no) 1990-01-26 1992-07-24 Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener

Country Status (10)

Country Link
EP (2) EP0511967B1 (no)
JP (2) JPH05506565A (no)
AT (1) ATE134649T1 (no)
AU (1) AU653141B2 (no)
CA (2) CA2074512A1 (no)
DE (1) DE69025629T2 (no)
ES (1) ES2082962T3 (no)
FI (1) FI923348A (no)
NO (1) NO922941L (no)
WO (2) WO1991011528A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651113B2 (en) * 1990-06-18 1994-07-14 Abbott Laboratories HIV GP120 monoclonal antibodies
US6800468B1 (en) 1998-11-13 2004-10-05 Henrik Clausen UDP-galactose: β-N-acetyl-glucosamine β1,3galactosyltransferases, β3Gal-T5
CA2350079A1 (en) 1998-11-13 2000-05-25 Henrick Clausen Udp-galactose: beta-n-acetyl-glucosamine beta1,3galactosyltransferases. beta3gal-t5
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット
EP0357767B1 (en) * 1988-03-11 1995-05-24 The Biomembrane Institute Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates

Also Published As

Publication number Publication date
JPH05506843A (ja) 1993-10-07
EP0511967A1 (en) 1992-11-11
JPH05506565A (ja) 1993-09-30
FI923348A0 (fi) 1992-07-23
ATE134649T1 (de) 1996-03-15
NO922941D0 (no) 1992-07-24
EP0512023A1 (en) 1992-11-11
FI923348A (fi) 1992-07-23
ES2082962T3 (es) 1996-04-01
EP0511967B1 (en) 1996-02-28
CA2074512A1 (en) 1991-07-27
EP0512023A4 (en) 1993-06-30
WO1991011199A1 (en) 1991-08-08
AU6961491A (en) 1991-08-21
CA2073459A1 (en) 1991-07-27
AU653141B2 (en) 1994-09-22
WO1991011528A1 (en) 1991-08-08
DE69025629T2 (de) 1996-07-04
DE69025629D1 (de) 1996-04-04

Similar Documents

Publication Publication Date Title
NO944475D0 (no) Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener
NO302176B1 (no) Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen
DE69329621D1 (de) MONOKLONALE ANTIKöRPER GEGEN DEFINIIERTE REGIONEN DES T-ZELL-ANTIGENREZEPTORS
ZA884651B (en) Monoclonal antibody specific to hiv antigens
DK98187A (da) Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma
FI931393A (fi) Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
DK0474691T3 (da) Monoklonale antistoffer til induktion af tolerance
DK282987D0 (da) Lagdelt immunoanalyseorgan til bestemmelse af et antigens tilstedevaerelse, og hvori der anvendes antistoffer beregnet til transport af partikler
AU525403B2 (en) Purified antigen
NO922941L (no) Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener
NZ195756A (en) Human cancer cell-associated nucleolar antigens and antibodies thereto;immunological detection of cancer
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
DE3485712D1 (de) Monoklonale antikoerper gegen menschliche nierenkrebsantigene und verfahren.
DK140992D0 (da) Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug
EP0511300A4 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
ATE2048T1 (de) Isolierung von hepatitis be-antigen.
EP0293184A3 (en) Immunodiagnostic assays using chimeric antigens
ES2059539T3 (es) Metodo para la prevencion de la enfermedad del injerto frente al huesped.
IT1254570B (it) Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione.
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
NO900609L (no) Monoclonale antistoffer mot epiteliale linseceller og fremgangsmaater for forhindring av formering av epiteliale linserestceller etter ekstrakapsulaer ekstraksjon.
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
BG51731A1 (en) Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody against antigenic deternimant, common for the strains hantaan and finnish of the virus of haemorrhagic fever with nephritic syndrome
NO930883L (no) Peptider for bruk ved vaksinasjon og induksjon av noeytraliserende antistoffer mot hiv